While the global conversation about artificial intelligence often gravitates toward its dazzling potential to discover new medicines, the most profound and immediate transformation is quietly taking place on the pharmaceutical factory floor. This analysis dissects the pervasive hype surrounding AI
A sudden and dramatic 73% surge in a biotechnology company's stock price following early trial data has ignited conversations across the pharmaceutical industry, signaling a potential new contender in one of medicine's most competitive arenas. Evommune, a company founded by dermatology
The neighborhood pharmacy, once viewed primarily as a convenient stop for prescriptions, is rapidly becoming one of the most pivotal assets in a modern hospital's strategic arsenal, fundamentally reshaping how health systems manage costs, outcomes, and patient relationships. This
The multi-billion-dollar price tag attached to a pharmaceutical acquisition often captures headlines, but the true significance of Eli Lilly's $2.4 billion deal for Orna Therapeutics lies in the revolutionary science it aims to command. This is not merely a financial transaction; it represents
The quiet closure of a rural hospital sends a ripple effect far beyond its empty corridors, fundamentally altering the health, security, and economic stability of an entire community for generations. For decades, these essential institutions have been caught in a downward spiral of financial strain
With the national debate on healthcare spending reaching a fever pitch, we sat down with Faisal Zain, a leading expert in medical technology and healthcare systems, to cut through the noise. His work, which spans both the manufacturing of innovative medical devices and the analysis of the policies
